René Rizzoli wins prestigious Pierre Delmas Prize: An ESCEO-IOF-Servier Achievement Award

March 21, 2012

Today, in Bordeaux, France, the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF), with the support of Servier, awarded the prestigious Pierre Delmas Prize: An ESCEO-IOF-Servier Achievement Award to Professor René Rizzoli.

The Pierre Delmas Prize, valued at 40 000 EUR, is awarded to an individual investigator for outstanding and major scientific contributions to the study of bone and mineral diseases. The award is named after the late Pierre Delmas, professor of Medicine and Rheumatology at the University of Lyon, France, who made major contributions to basic and clinical research in the field, and, as the founding President of IOF, had a profound impact on the development of osteoporosis advocacy worldwide.

ESCEO President Jean-Yves Reginster stated, "In keeping with the spirit of the Pierre Delmas Prize, Professor Rizzoli is recognized for both his outstanding achievements as a scientist in the field of metabolic bone disease and his long-term accomplishments as an educator and advocate in the osteoporosis arena."

René Rizzoli is professor of medicine at University Hospitals of Geneva and head of the service of bone diseases at the Department of Rehabilitation and Geriatrics, of which he is also the chairman. He is Vice Chair of IOF Committee of Scientific Advisors (having chaired the Committee for its first eight years) and is former president of the Swiss Association Against Osteoporosis. He is presently member of the IOF Executive Committee, and also chairs the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. Professor Rizzoli is involved in both basic and clinical research projects investigating hormone action, calcium, bisphosphonates, selective estrogen modulators and strontium ranelate in the prevention and treatment of osteoporosis. He is the author of almost 600 publications, and is associate editor of leading bone journals including 'Bone' and 'Osteoporosis International'.

IOF President John A. Kanis, co-presenter of the award, commented, "As one of the leading investigators in the field, René Rizzoli's outstanding work in the area of metabolic bone diseases, osteoporosis and disorders of mineral metabolism and bone nutrition is highly regarded internationally. IOF is honoured to award this prestigious prize to an exceptional scientist, author and educator who has contributed enormously to the bone field in so many ways."

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members - including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe - share a common vision of a bone healthy future without fragility fractures. IOF now represents more than 200 societies in all regions of the world.


The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to